Top Markets
#1 MowCat MowCat +781.17%
#2 Islamic Coin Islamic Coin +152.10%
#3 龙虾 (Lobster) 龙虾 (Lobster) +85.52%
#4 Akedo Akedo +63.14%
#5 MarsCoin MarsCoin +47.18%
#6 Magma Finance Magma Finance +42.73%
#7 Pons Pons +34.51%
#8 DeXe DeXe +30.37%
#9 SIXSEVEN SIXSEVEN +30.31%
#10 Cortex Cortex +26.53%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Clasificación en acciones #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Precio por acción
$25.61
Última sincronización: 2025-10-10
Capitalización bursátil
$1.37B
Cambio (1 día)
0.20%
Cambio (1 año)
1.59%
País
US
Comercio Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Categoría

Healthcare
Ingresos de Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Harrow Health, Inc. 8.625% Senior Notes due 2026, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Harrow Health, Inc. 8.625% Senior Notes due 2026 desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $4.55B -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT